What does this research mean for the field?

FAPI PET/CT demonstrates excellent diagnostic performance for lung tumors and non-tumor lesions. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The research aims to assess the effectiveness of FAPI PET/CT in diagnosing lung diseases, particularly non-oncological ones.

March 13, 2026PulmonologyOpen Access

Fibroblast-activation protein inhibitors based positron emission tomography (PET) for assessing lung disease: A systematic review with meta-analysis

View Full Paper

Ask AI

Bookmark

The research aims to assess the effectiveness of FAPI PET/CT in diagnosing lung diseases, particularly non-oncological ones.
Systematic review of existing literature on FAPI PET/CT for lung disease assessment.
Meta-analysis to evaluate diagnostic performance across studies.
Inclusion of studies assessing both tumours and non-tumour lesions.
FAPI PET/CT shows excellent diagnostic performance for identifying lung tumours.
CT scans often fail to accurately diagnose conditions like IPF, leading to treatment delays.
Meta-analysis supports FAPI PET's potential in both oncological and non-oncological lung disease assessments.

Implication

Meta-analysis evaluates diagnostic performance of FAPI PET for lung disease, suggesting new pathways for assessment.

Abstract

Our results show that FAPI PET/CT has an excellent diagnostic performance for lung tumours and non-tumour lesions.Points for clinical research: Currently CT is unable to accurately determine the activity of lung diseases such as IPF and hence may lead to delays in the diagnosis and treatment of some lung diseases. We aimed to find evidence-based medical evidence suitable for FAPI PET in lung diseases, especially non-oncological diseases, by performing a meta-analysis of FAPI PET in assessing lung diseases.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/69b3ac2b02a1e69014ccdaee https://doi.org/10.1080/25310429.2026.2638024

View Full Paper

Ask AI

Bookmark

Implication

Meta-analysis evaluates diagnostic performance of FAPI PET for lung disease, suggesting new pathways for assessment.

Fibroblast-activation protein inhibitors based positron emission tomography (PET) for assessing lung disease: A systematic review with meta-analysis

Key Points

Implication

Abstract

Discussion

Cite This Study

Fibroblast-activation protein inhibitors based positron emission tomography (PET) for assessing lung disease: A systematic review with meta-analysis

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading